The Opportunity

Abbott Rapid Diagnostics is part of Abbott’s Diagnostics family of businesses, bringing together exceptional teams of experts and industry leading technologies to support diagnostic testing which provides important information for treatment and management of diseases and other conditions.

The Abbott Rapid Diagnostics Infectious Diseases Division (ARDx) portfolio is centred around ID Now. A fast growing, molecular testing platform with the flexibility to test for Covid-19, Influenza A &B, RSV and Strep A.

The ID NOW delivers accurate results in just minutes, giving HCPs real-time access to the information required to make actionable decisions during the first patient visit.

The ID NOW Platform provides diagnostics where and when they are needed most — in near patient settings at the point of care such as Emergency departments, Admissions and Wards.

Other products within the portfolio include Binax NOW rapid antigen t...